Delivery Order SPE2DB22D3016-SPE2DB25FBCW1
- Not listed
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, valued at $1,068.57. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,558.39. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award eligibility. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $6,435.48 and a firm fixed price structure. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a $6,747.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between June 28-29, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the Defense Logistics...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,960.66 delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product used to treat various eye conditions. The contract has an ultimate completion date of August 13, 2024 and utilizes a Firm Fixed Price pricing structure. Amerisourcebergen, a major pharmaceutical distributor in the United States,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCW1Delivery Order
The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The award represents work performed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in delivering pharmaceutical products through competitive procurements with the Defense Logistics Agency across multiple therapeutic domains. The company's existing IDC with DLA Troop Support Medical serves as the underlying vehicle for this delivery order, supporting critical military healthcare requirements through the company's pharmaceutical distribution network. This delivery order for ophthalmic medication reflects AmerisourceBergen's ongoing role as a prime vendor supplying specialized pharmaceutical commodities to support Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/23/25 |